ID
NKTR icon

Integral Derivatives’s Nektar Therapeutics NKTR Stock Holding History

Integral Derivatives’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,673
Closed -$2.4M – 893
2017
Q4 		$2.4M Sell
2,673
-227
-8% -$134K 0.05% 249
2017
Q3 		$1.04M Buy
2,900
+67
+2% +$21K 0.02% 484
2017
Q2 		$831K Sell
2,833
-1,347
-32% -$389K 0.02% 541
2017
Q1 		$1.47M Buy
+4,180
New +$940K 0.03% 409
2015
Q1 		– Sell
-667
Closed -$155K – 1296
2014
Q4 		$155K Hold
667
– – ﹤0.01% 1255
2014
Q3 		$121K Hold
667
– – ﹤0.01% 1314
2014
Q2 		$128K Hold
667
– – ﹤0.01% 1254
2014
Q1 		$121K Hold
667
– – ﹤0.01% 1217
2013
Q4 		$114K Buy
+667
New +$108K ﹤0.01% 1403

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return